Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 28, 2017; 23(8): 1450-1457
Published online Feb 28, 2017. doi: 10.3748/wjg.v23.i8.1450
Published online Feb 28, 2017. doi: 10.3748/wjg.v23.i8.1450
Table 1 Association analysis of immunohistochemistry staining for Arpin vs clinicopathological factors of gastric cancer, n (%)
| Clinicopathological features | Number of patients (n = 176) | Arpin expression | χ2 | P value | |
| High (n = 54) | Low (n = 122) | ||||
| Age (yr) | |||||
| > 50 | 97 (55.11) | 29 (29.90) | 68 (70.10) | 0.063 | 0.802 |
| ≤ 50 | 79 (44.89) | 25 (31.65) | 54 (68.35) | ||
| Gender | |||||
| Male | 110 (62.50) | 31 (28.18) | 79 (71.82) | 0.865 | 0.353 |
| Female | 66 (37.50) | 23 (34.85) | 43 (65.15) | ||
| Tumer size (cm) | |||||
| > 5 | 120 (68.18) | 37 (30.83) | 83 (69.17) | 0.004 | 0.949 |
| ≤ 5 | 56 (31.82) | 17 (30.36) | 39 (69.64) | ||
| Depth of invasion | |||||
| T1 + T2 | 44 (25.00) | 24 (54.55) | 20 (45.45) | 15.79 | 0.000 |
| T3 + T4 | 132 (75.00) | 30 (22.73) | 102 (77.27) | ||
| Lymph node metastasis | |||||
| Yes | 131 (74.43) | 25 (19.08) | 106 (80.92) | 32.404 | 0.000 |
| No | 45 (25.57) | 29 (64.44) | 16 (35.56) | ||
| TNM stage | |||||
| I | 70 (39.77) | 30 (42.86) | 40 (57.14) | 9.379 | 0.009 |
| II | 50 (28.41) | 14 (28.00) | 36 (72.00) | ||
| III | 56 (31.82) | 10 (17.86) | 16 (82.14) | ||
| Histology | |||||
| Well + moderate | 80 (45.45) | 21 (26.25) | 59 (73.75) | 1.354 | 0.245 |
| Poor | 96 (54.55) | 33 (34.38) | 63 (65.62) | ||
| Tumor site | |||||
| Upper | 66 (37.50) | 24 (36.36) | 42 (63.64) | 1.648 | 0.439 |
| Middle | 16 (9.09) | 4 (25.00) | 12 (75.00) | ||
| Low | 94 (53.41) | 26 (27.66) | 68 (72.34) | ||
- Citation: Li T, Zheng HM, Deng NM, Jiang YJ, Wang J, Zhang DL. Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer. World J Gastroenterol 2017; 23(8): 1450-1457
- URL: https://www.wjgnet.com/1007-9327/full/v23/i8/1450.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i8.1450